GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the ...
Inogen devices are known for their superior patient compliance, monitoring and diagnostic capabilities and we know that continued investment in our platforms to improve their ease of use and cost ...
(1) Stockholder engagement and proxy defense costs include third-party advisory, legal, and other professional fees. (2) Income tax impact of adjustments represents the tax impact related to the ...
“2024 was a very successful year for Inogen (INGN). We drove a return to revenue growth, improved profitability and disciplined cost management. Achievements in the quarter included the launch of Rove ...
Zacks Investment Research on MSN
Here's why you should retain Inogen stock in your portfolio for now
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results